Hwan Bong Jang

Title: Hwan Bong Jang: Innovator in Pharmaceutical Chemistry

Introduction

Hwan Bong Jang is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Hwan Bong Jang holds a patent for "5-pyrimidinecarboxamide derivatives and the pharmaceutical compositions containing said derivatives." This invention relates to novel 5-pyrimidinecarboxamide derivatives and their pharmacologically active salts. The patent outlines the process for preparing these compounds and the pharmaceutical compositions that utilize them as active ingredients. Notably, these derivatives exhibit inhibitory activity against the proliferation of human immunodeficiency virus (HIV) and hepatitis B virus (HBV). As such, they can serve as both therapeutic and preventive agents for hepatitis B and acquired immune deficiency syndrome (AIDS).

Career Highlights

Hwan Bong Jang is associated with Dongwha Pharm. Ind. Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions in the pharmaceutical industry.

Collaborations

Hwan Bong Jang collaborates with esteemed colleagues, including Jong Woo Kim and Nam Doo Kim. Their combined expertise contributes to the success of their projects and the advancement of pharmaceutical research.

Conclusion

Hwan Bong Jang's contributions to pharmaceutical chemistry, particularly through his patent on 5-pyrimidinecarboxamide derivatives, highlight his role as an innovator in the field. His work not only addresses critical health issues but also showcases the importance of collaboration in scientific research.